Inventor · disambiguated record
Rong Liu
Also filed as: LIU RONG · LIU RONG-QIANG
10 granted patents·8 pending applications·332 citations·filing 1996–2024
91Inventor score
Top patents by PatentIndex Score
18 records- 0196US5939320AG-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereofUNIV NEW YORK·Filed 1996·Granted Aug 17, 1999·174 cites·9 claims
- 0289US8148391B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitorsAHMED GULZAR·Filed 2007·Granted Apr 3, 2012·17 cites·8 claims
- 0385US8552186B2Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitorsAHMED GULZAR·Filed 2012·Granted Oct 8, 2013·10 cites·26 claims
- 0485US7803828B2Functionally selective alpha2C adrenoreceptor agonistsSCHERING PLOUGH CORP·Filed 2006·Granted Sep 28, 2010·9 cites·17 claims
- 0584US7700592B2α2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·8 cites·11 claims
- 0680US7129055B2Methods of identifying g-couple receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereofUNIV NEW YORK·Filed 2000·Granted Oct 31, 2006·18 cites·1 claims
- 0780US6258527B1Methods of identifying g-coupled receptors associated with macrophage-trophic HIV, and diagnostic and therapeutic uses thereofAARON DIAMOND AIDS RES CT·Filed 1997·Granted Jul 10, 2001·53 cites·20 claims
- 0876US2025123281A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2024·Application pending·0 cites
- 0972US7985748B2ALPHA2C adrenoreceptor agonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2010·Granted Jul 26, 2011·2 cites·15 claims
- 1063US6057102AHIV coreceptor mutantsAARON DIAMOND AIDS RESEARCH CE·Filed 1997·Granted May 2, 2000·41 cites·13 claims
- 1160US2021128619A1Uses of anti-bcma chimeric antigen receptorsCELGENE CORP·Filed 2020·Application pending·0 cites
- 1260US2024174693A1Somatostatin receptor subtype 4 (sstr4) agonists and their applicationsHumanwell Pharmaceutical US·Filed 2023·Application pending·0 cites
- 1357US2024400554A1Monoacylglycerol lipase (magl) inhibitors for the treatment of pain and related medical disordersHUMANWELL PHARMACEUTICAL US INC·Filed 2024·Application pending·0 cites
- 1456US2025326755A1Cyclic quaternary ammonium salt compound, and preparation method therefor and use thereofYICHANG HUMANWELL PHARMACEUTICAL CO LTD·Filed 2023·Application pending·0 cites
- 1555US2010119483A1Peptide viral entry inhibitorsSCHERING CORP·Filed 2009·Application pending·0 cites
- 1652US2022354923A1Peptides for treatment of medical disordersHumanwell Pharmaceutical US·Filed 2022·Application pending·0 cites
- 1751US2007093477A1Alpha2C adrenoreceptor agonistsSCHERING CORP AND PHARMACOPEIA·Filed 2006·Application pending·0 cites
- 1849US7592315B2Peptide viral entry inhibitorsSCHERING CORP·Filed 2005·Granted Sep 22, 2009·0 cites·38 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →